Measure of Y-glass microspheres residue post-TARE using PET/CT and potential impact on tumor absorbed dose in comparison Tc-MAA SPECT/CT dosimetry.

Background: Transarterial radio-embolization (TARE) became a routine procedure for non-resectable liver tumor mainly hepatocellular carcinoma (HCC). Personalized dosimetry to the index lesion increased tumor response rate. However, there is no requirement to measure the precise activity injected during TARE.

Lymphopenia during Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report.

We report the case of a 72-year-old woman who presented with tuberculous arthritis during the setting of Lu-DOTATATE therapy for a grade-2 neuro-endocrine pancreatic tumor with liver metastases. We hypothesized that this recurrence might have been related to the occurrence of lymphopenia, which is common during PRRT. Indeed, though lymphopenia is frequently dismissed, it could lead to the development of opportunistic diseases and its severity should be examined, especially in case of abnormal clinical symptoms.